aATG, anti-thymocyte globulin. bMMF, mophetil mycophenolate. cRAD, rapamycin derivative. dns, not significant. Factors potentially associated with patient distribution into the four groups.
This study is a multicenter, prospective, randomized (1:1), open-label, Phase II study to compare a NULOJIX (belatacept) based immunosuppressive regimen to a CNI-based regimen in recipients of SPK. Su
Immunology Database and Analysis Portal2025-10-30 更新30
This study is a multicenter, prospective, randomized (1:1), open-label, Phase II study to compare a NULOJIX (belatacept) based immunosuppressive regimen to a CNI-based regimen in recipients of SPK. Su
ABSTRACT Objective: To evaluate the technique of uterine transplantation and the use of drugs used in the process of immunosuppression. Methods: We included 12 sows, and immunosuppression was perfor
